title: Recent trial shows that solanezumab has disease modifying effects.
authors: Alzheimer's Research UK, Cambridge CB21 6AD, UK k.marais@alzheimersresearchuk.org.
authors: Eric
authors: E
authors: Karran
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D006801:Humans; D008402:Mass Media
chemical_list: D061067:Antibodies, Monoclonal, Humanized